Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1Phase 1 1

Status

Completed 18Unknown 8Recruiting 5Not yet recruiting 5Terminated 2Enrolling by invitation 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Breast 2Plasma cell 1Other 1Classical hematology 1

Conditions

Breast Neoplasms 2Weight Loss 1Pediatric Obesity 1Obesity 1Neoplasms 1Multiple Myeloma 1Emotional Regulation 1Anemia 1

Interventions

pembrolizumab 555Specimen Handling 459Carboplatin 446Magnetic Resonance Spectroscopy 427Cyclophosphamide 412Cisplatin 404Gemcitabine 314Radiotherapy 313Bevacizumab 310Paclitaxel 300Biopsy 260Drug Therapy 252Capecitabine 241Oxaliplatin 240fludarabine 236Nivolumab 226venetoclax 225Injections 214Docetaxel 203Fluorouracil 201Dexamethasone 186Radiosurgery 172Rituximab 161Pemetrexed 157durvalumab 144Standard of Care 143atezolizumab 139toripalimab 137tislelizumab 137Leucovorin 137

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Interventional × Population Groups × Clear all
NCT07144800 2026-04-15

Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
1,319 enrolled
Other

Obesity, Weight Loss, Pediatric Obesity

NCT07236021 2025-11-21

e-Motion : Promoting Emotion Regulation in Chronic Cancer

Université Libre de Bruxelles

Phase NA Recruiting
30 enrolled
Plasma cell

Emotional Regulation, Multiple Myeloma, Neoplasms

NCT05984888 2025-10-03

MIND-BC

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
43 enrolled
Breast

Breast Neoplasms

NCT06770296 2025-01-13

The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase I Clinical Study

The First Affiliated Hospital with Nanjing Medical University

Phase 1 Recruiting
200 enrolled
Breast

Breast Neoplasms

NCT06737081 2024-12-17

SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies

Shenzhen Salubris Pharmaceuticals Co., Ltd.

Phase 2 Recruiting
60 enrolled
Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡